Hawkins, Inc. reported Q4 fiscal 2026 results after the close on May 13 — EPS of $0.74 missed the $0.78 estimate while revenue of $265.9 million beat the $255.3 million consensus. The setup heading in told the whole story: options traders had turned meaningfully more defensive over the past week even as short sellers were quietly backing away.
The sharpest signal into the print came from the options market. The put/call ratio jumped to 0.82, more than 2.5 standard deviations above its 20-day mean of 0.62 — the most defensive positioning has looked in months. That is a notable shift from the prior three weeks, when the PCR barely moved off 0.56. The move suggests investors were hedging downside rather than positioning for a clean beat. That caution proved warranted: the EPS miss was narrow but sufficient to disappoint after a 14% rally over the prior month.
Short interest tells a less aggressive story heading in. Bears covered hard over the past week — estimated shares short fell roughly 17% over seven days to around 4.9% of the free float, the lowest level in six weeks. Borrowing costs remain negligible at 0.47% annualised, with share availability relatively loose at around 20% of the lending pool used. The ORTEX short score of 51.8 is mid-range and has drifted down from 56.3 at the start of the month. Short sellers, in aggregate, were not pressing their bet into this number.
The Street remains sparsely covered. BWS Financial holds a lone Buy rating with a $200 target — implying 19% upside from the pre-print price. Raymond James initiated at Market Perform last July with no target attached, a cautious flag from a firm that otherwise follows the space closely. With only two covering analysts and the mean target at $166 (essentially in line with where the stock traded at $168.59 before results), there was no meaningful top-down directional conviction. Valuation looked stretched on a trailing basis at a P/E of 38.6x and EV/EBITDA of 18.3x — multiples the market was prepared to pay as long as the growth narrative held. The EPS miss tests that tolerance. Factor scores offer one genuine bright spot: the forward earnings estimate momentum score ranks in the 90th percentile for year-on-year growth, suggesting analysts still see the growth arc intact even after this stumble.
On the ownership side, the March 30 insider cluster is worth noting. CEO Patrick Hawkins sold $1.66 million worth of shares, CFO Jeffrey Oldenkamp sold $860,000, and three vice presidents sold a combined $1.7 million — all on the same day at $151.62. That coordinated sale, at a price well below where the stock subsequently rallied, may reflect scheduled plan disposals rather than a directional call, but the timing ahead of Q4 results adds a layer of context. Director James Faulconbridge ran the other way in February, buying 3,000 shares at around $129-130, just ahead of the February quarter report that drove an 8% one-day gain. BlackRock and State Street both added to positions in the most recent filing period — institutional flows are not alarming, but they are not accelerating sharply either.
Earnings reactions have been volatile. The February quarter print produced an 8% one-day rally and a 13% five-day gain. The January report produced the mirror image: a 9% drop on day one and a 16% slide over five days. With tonight's EPS miss now in the open, the focus will be on management commentary around industrial demand, the water treatment segment, and whether the revenue beat can sustain the premium multiple — or whether the earnings miss pulls the multiple back toward the EV/EBITDA compression already showing in the 30-day data.
See the live data behind this article on ORTEX.
Open HWKN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
